InChI=1S/C19H36O5/c1- 18(2,16(21) 22) 13- 9- 5- 7- 11- 15(20) 12- 8- 6- 10- 14- 19(3,4) 17(23) 24/h15,20H,5- 14H2,1- 4H3,(H,21,22) (H,23,24) |
HYHMLYSLQUKXKP-UHFFFAOYSA-N |
C(C(CCCCCC(CCCCCC(C(O)=O)(C)C)O)(C)C)(O)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
EC 2.3.3.8 (ATP citrate synthase) inhibitor
An EC 2.3.3.* (acyltransferase converting acyl to alkyl group on transfer) inhibitor that interferes with the action of ATP citrate synthase (EC 2.3.3.8).
|
|
antilipemic drug
A substance used to treat hyperlipidemia (an excess of lipids in the blood).
prodrug
A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
|
|
View more via ChEBI Ontology
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
|
acide bempédoïque
|
WHO MedNet
|
ácido bempedoico
|
WHO MedNet
|
acidum bempedoicum
|
WHO MedNet
|
bempedoic acid
|
WHO MedNet
|
ESP 55016
|
ChemIDplus
|
ESP-55016
|
ChemIDplus
|
ETC 1002
|
ChemIDplus
|
ETC-1002
|
ChemIDplus
|
ETC1002
|
ChemIDplus
|
738606-46-7
|
CAS Registry Number
|
ChemIDplus
|
|